Annexon Announces Proposed Public Offering of Common Stock
BRISBANE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of...
Stay updated with breaking news from Sheryl Seapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BRISBANE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of...
BRISBANE, Calif., June 04, 2024 -- Annexon, Inc. , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical...
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib...
BURLINGAME, Calif., May 02, 2024 -- Corvus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase agreement with new...
BURLINGAME, Calif., May 02, 2024 -- Corvus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on May 6,...